Evidence Hub

Gaze Contingent Feedback in Major Depressive Disorder

ClinicalTrials.gov · COMPLETED, 2019

60 participants

Abstract

The purpose of this study is to determine whether giving gaze-contingent feedback is an effective attention modification procedure, helping in the treatment of Major Depressive Disorder (MDD)

Conditions: Depression, Unipolar, Depressive Disorder, Depressive Disorder, Major.

Primary outcome: Change from baseline - Structured Interview for the Montgomery-Asberg Depression Rating Scale (SIGMA).

Enrollment: 60 participants.

How strong is the evidence?

Evidence Hub reads this as a clinical trial, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 60 participants or records.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free